Shareholders to Sell 60M Medline Class A Shares with 9M Underwriter Option
Shareholders affiliated with Blackstone, Hellman & Friedman and the Abu Dhabi Investment Authority will sell 60 million Medline Class A shares, with underwriters granted a 30-day option on an additional 9 million shares. Medline will not sell shares or receive any proceeds from the offering.
1. Secondary Offering Structure
Selling stockholders have launched an underwritten public offering of 60 million Medline Class A shares, with underwriters granted a 30-day overallotment option to purchase up to an additional 9 million shares. The offering is being structured through a registered prospectus filed with the SEC, pending effectiveness.
2. Selling Stockholders Profile
The shares are being sold by entities affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority. These selling shareholders are liquidating existing holdings rather than expanding Medline’s capital base.
3. Company Impact
Medline is not issuing new shares and will receive no proceeds from this transaction, meaning the company’s cash position remains unchanged. However, the increased share supply could exert downward pressure on the stock’s market price in the short term.
4. Underwriting and Regulatory Process
Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan are acting as global coordinators and joint bookrunners, with Blackstone Capital Markets as co-manager. The sale cannot occur until the SEC registration statement becomes effective under securities laws.